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1. INTRODUCTION 
1.1 Primary sensory neurons: the eminent players of somatovisceral functions  
In 1908, Sir Henry Head and William Halse Rivers have published their findings on the 
classification of sensations. At St. John’s College, Cambridge, J. Sherren has divided the 
cutaneous branch of the radial nerve of Head by his persuasion to map the sensory loss caused 
by nerve injury and the restoration of function by the regeneration of the nerve. Head has 
observed that there are three disparate forms of sensations: deep, epicritic and protopathic 
sensibilities. He suggested that protopathic sensibility involves sensations evoked by painful 
pressure and thermal stimuli, whereas epicritic sensibility subserves fine and discriminative 
touch sensations (Head et al., 1905; Rivers and Head, 1908). Later, it has been revealed that 
there exist two anatomically, morphologically and functionally disparate pathways for epicritic 
and protopathic sensibility: the medial lemniscus pathway and the spinothalamic pathway and 
their trigeminal counterparts: the dorsal and the ventral trigeminal lemniscus pathways. Further, 
there are two anatomically and functionally different pathways which detect stimuli originating 
from the body surface and the musculoskeletal system (somatic sensory system), and the 
visceral organs (viscerosensory system), respectively. 
The cell bodies of the pseudo-unipolar neurons, the key players and the first-order neurons of 
somato- and viscerosensory pathways, are localised in the dorsal root ganglia (DRGs), and in 
the sensory ganglia of the Vth, VIIth, IXth and Xth cranial nerves. Somatic and visceral primary 
sensory neurons (PSNs) possess central and peripheral axonal branches and are involved, inter 
alia, in the detection of nociceptive/painful stimuli. The peripheral branches of different classes 
of PSNs end in specific sensory nerve endings which detect non-noxious mechanical and 
thermal stimuli and noxious/painful mechanical, chemical and thermal stimuli originating in 
the skin, the musculoskeletal system and the visceral organs. The central branches of PSNs 
project to the central nervous system (CNS) via the dorsal (sensory) roots of spinal and cranial 
nerves. The axons of the second-order neurons cross over in the ventral white commissure of 
the spinal cord and ascend via the lateral or the ventral spinothalamic tract. However, ascending 
visceral pathways include other tracts such as the dorsal columns, the spinoreticular, 
spinomesencephalic and spinoparabrachial tracts. Nevertheless, the cranial sensory axons of the 
second-order neurons located in the spinal trigeminal nucleus cross over in the medulla 
oblongata and comprise the ventral trigeminal lemniscus pathways.  
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Third-order neurons of distinct functional properties are located and segregated in the specific 
nuclei of the thalamus. For example, fibres which convey visceral sensory information are 
synapsing with neurons in the parafascicular nucleus, whereas neurons transmitting nociceptive 
information from the body surface are synapsing with neurons in the ventral posterolateral 
nucleus and the medial thalamic nuclei. Thalamic neurons project to the primary somatosensory 
cortex, although other cortical areas, such as the insular cortex are also involved. 
1.1.1. Morphological and functional classification of primary sensory neurons 
Based on the findings of Head and Rivers (1908), Gasser and Erlanger (1927) showed that PSNs 
in spinal and cranial sensory ganglia can be classified into three main categories: neurons with 
fast conducting myelinated A- and B-fibres and neurons with slowly-conducting unmyelinated, 
C-fibres (Gasser and Erlanger, 1927). Fibres of type A are frequently subdivided into A, A 
and A-fibres based on their different conduction velocities. Besides this classification, Lloyd 
and Hunt proposed a slightly different categorization by studying reflex activities in animals. 
They classified sensory nerve fibres into four size-groups by their diameters: type I-fibres which 
are equivalent to the myelinated A-fibres, type II-fibres identical with cutaneous afferent 
myelinated A-fibres, type III-fibres and type IV-fibres representing the myelinated A and 
unmyelinated C-fibres, respectively (Lloyd, 1943; Hunt, 1951) (Table 1).  
Morphologically spinal and cranial sensory ganglion neurons can be divided into two main 
categories: type A or large light neurons and type B or small dark neurons (Andres, 1961; 
Lawson and Biscoe, 1979; Lawson et al., 1984). This classification is based on ontogenetic, 
neurochemical and morphological properties (Lawson and Biscoe, 1979). 
Immunohistochemical and electron microscopic findings have also revealed that A-type PSNs 
are rich in neurofilaments and contain distinctly organized accumulation of cisterns of rough 
endoplasmic reticulum (Nissl bodies), while type B neurons contain few neurofilaments and 
less organized rough endoplasmic reticulum. By using anti-neurofilament antibodies, it has also 
been demonstrated that type A neurons show intense immunohistochemical staining for the 200 
kDa neurofilament subunit, whereas type B neurons show immunohistochemical staining for 
the 66 kDa neurofilament subunit peripherin (Lawson et al., 1984; Lawson and Waddell, 1991; 
Sann et al., 1995). Neurofilament-rich, large-sized type A neurons have myelinated Aα-, Aβ- 
or Aδ-fibres, whereas neurofilament-poor, small-sized type B neurons give rise to unmyelinated 
C-fibres (Lawson et al., 1984) (Table 1).  
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Lloyd-Hunt 
classification 
Gasser-Erlanger 
classification 
Diameter 
(m) 
Conduction 
velocity  
(m/s) 
Myelin 
Neurofilament 
content 
Ia A 13-20 80-120 yes 
200 kDa 
(type A) 
Ib A 13-20 80-120 yes 
200 kDa 
(type A) 
II A 6-12 33-75 yes 
200 kDa 
(type A) 
III A 1-5 3-30 yes 
200 kDa 
(type A) 
IV C 0.2-1.5 0.5-2.0 no 
66 kDa 
(type B) 
Table 1. Classification of primary sensory neurons by morphological and functional properties 
 
Functionally, PSNs can be divided into two main categories: first, PSNs which transmit non-
noxious mechanical and thermal stimuli and largely correspond to type A PSNs with large and 
thinly myelinated axons. The other category is comprised of nociceptive PSNs, which transmit 
impulses evoked by noxious mechanical, thermal and chemical stimuli and are comprised 
largely of type B PSNs. The subject matter of this Thesis is confined largely to investigations 
into the morphological and neurochemical characteristics of nociceptive PSNs. Therefore, in 
the next chapter, the morphological, functional and neurochemical properties of nociceptive 
PSNs will be described in some detail.     
1.1.2. Basic functional morphology and neurochemical traits of C-fibre primary sensory 
neurons                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
Sensation of pain elicited by noxious mechanical, chemical or thermal stimulation of the skin, 
the musculoskeletal system and the visceral organs are detected by nociceptors. The term, 
nociceptor was introduced by Sherrington who described nociceptors as a special type of PSNs 
with differing sensitivities and thresholds for painful stimuli that distinguish them from other 
classes of sensory neurons (Sherrington, 1906). Morphologically, nociceptors are of two types: 
myelinated Aδ and Aβ-fibre nociceptors, and unmyelinated C-fibre nociceptors (Djouhri and 
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Lawson, 2004). C-fibres can be classified on the basis of their sensitivity to different stimuli: 
polymodal nociceptors, which are sensitive to mechanical, chemical and thermal stimuli and 
the C-mechanoinsensitive afferents (Beck and Handwerker, 1974; LaMotte and Campbell, 
1978; Meyer and Campbell, 1981).  
Besides the morphological differences between disparate sub-classes of nociceptors, C-fibre 
PSNs can be classified by other neurochemical and functional properties. Earlier studies have 
revealed that C-fibre PSNs can be divided into two neurochemically and functionally distinct 
subpopulations: peptidergic and non-peptidergic neurons (Hökfelt et al., 1975; Price, 1985; 
Silverman and Kruger, 1988; Silos-Santiago et al., 1995; Bennett et al., 1998; Snider and 
McMahon, 1998). Histochemical studies have demonstrated that about 30-50% of small-
medium sized DRG neurons express the enzyme fluoride-resistant acid phosphatase (FRAP) 
identical with neurons expressing thiamine monophosphatase (TMP, Inomata and Ogawa, 
1981; Knyihar-Csillik et al., 1986; Silverman and Kruger, 1990). It has also been revealed that 
practically all FRAP/TMP-positive sensory ganglion neurons are nociceptive in nature (Jancsó 
and Knyihár, 1975; Jancsó, 1992). TMP activity has also been demonstrated in the substantia 
gelatinosa Rolandi of the spinal dorsal horn, and in its trigeminal counterpart, the subnucleus 
gelatinosus of the spinal trigeminal nucleus (Jancsó and Knyihár, 1975; Jancsó and Király, 
1980; Jancsó et al., 1985). Recently, FRAP/TMP has been identified as the enzyme prostatic 
acid phosphatase (Taylor-Blake and Zylka, 2010). 
It has been demonstrated that many non-peptidergic neurons bind isolectin B4 (IB4), the lectin 
of the plant Griffonia simplicifolia (Bandeiraea simplicifolia) which has a high affinity for 
terminal α-galactosyl residues expressed by various cells including DRG neurons. IB4-binding 
C-fibre PSNs do not or rarely contain neuropeptides (Silverman and Kruger, 1990; Alvarez and 
Fyffe, 2000).  
The findings of Nikolaus (Miklós) Jancsó demonstrated that release of vasoactive substances 
from peripheral sensory nerve endings have a pivotal role in the mediation of neurogenic 
inflammatory responses (later termed the sensory efferent or local regulatory functions; cf. 
Jancsó et al., 2009). Early studies by Pavao Stern and his colleagues (Gasparovic et al., 1964) 
using bioassay techniques suggested that nociceptive C-fibre PSNs which mediate neurogenic 
inflammatory responses may contain peptides, such as substance P (SP). It is now well 
established that local vascular reactions mediated by nociceptive sensory nerves are effected by 
the release of various neuropeptides such as calcitonin gene-related peptide (CGRP) and SP 
(Gamse et al., 1980, 1987; Jancsó et al., 1985; Jancsó et al., 1987; Holzer, 1988; Maggi and 
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Meli, 1988; Szolcsányi, 1996). Although immunohistochemical studies have revealed that 
peptide-containing neurons comprise a unique population of small-medium sized C-fibre 
afferent neurons (Price, 1985), CGRP is also expressed by medium and large-diameter neurons 
(Ju et al., 1987). However, besides SP and CGRP, the two characteristic markers of peptidergic 
PSNs, other neuropeptides, such as galanin, cholecystokinin, vasoactive intestinal polypeptide, 
somatostatin, neurokinin A and pituitary adenylate cyclase-activating peptide are also 
expressed by C-fibre PSNs (Jancsó et al., 1981; Ju et al., 1987; Lazarov, 2002).  
CGRP was discovered by the analysis of the mRNA of calcitonin in the thyroid glands and 
hypothalamus of the rat. It has been shown that CGRP is widely expressed in neural tissues 
(Amara et al., 1982). After its discovery, it has been revealed that capsaicin induces CGRP 
release from sensory nerves endings, and CGRP is primarily localized to C and Aδ sensory 
fibres (Maggi, 1995). CGRP has a potent vasodilator activity (Brain et al., 1985) and contributes 
to neurogenic inflammation (for a historical review see Sousa-Valente and Brain, 2018). CGRP-
containing PSNs play a crucial role in several pathological processes such as vascular and 
inflammatory reactions in somatic and visceral tissues (Holzer, 1988; Maggi and Meli, 1988; 
Dux et al., 2003; Birder and Kullmann, 2018; Jaromi et al., 2018; Sousa-Valente and Brain, 
2018). 
SP is an 11-amino acid peptide belonging to the tachykinin peptide family. It has been 
discovered in gut extracts by U. S. v. Euler and J. H. Gaddum who identified it as a substance 
producing intestinal contraction (Euler and Gaddum, 1931). Later, it has been revealed that SP 
is abundant both in the periphery and in the CNS. SP is present in PSNs and in the spinal cord 
dorsal horn and is functionally related to nociception (Duggan et al., 1987). Moreover, SP 
results in plasma extravasation and has a potent vasodilator effect (Bossaller et al., 1992), thus, 
it is involved in local inflammatory processes, including neurogenic inflammation, and acts as 
a pro-inflammatory agent. SP is exclusively expressed by small-sized C-fibre PSNs which are 
sensitive to capsaicin (Hökfelt et al., 1975; Jancsó et al., 1981).   
Besides their different neuro(histo)chemical properties, peptidergic and non-peptidergic C-fibre 
PSNs have distinct developmental features, including their differential responsiveness to 
neurotrophins (Johnson et al., 1986). Silos-Santiago and his colleagues have revealed that 
nociceptive embryonic DRG neurons express the tyrosine kinase A (TrkA), the receptor for the 
nerve growth factor (NGF), and require NGF for survival (Silos-Santiago et al., 1995). 
However, the trophic factor sensitivity of rodent DRG neurons changes during the early 
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postnatal period. About 40-50% of small-sized sensory neurons lose their sensitivity to NGF 
and lack TrkA expression. These DRG neurons express TMP/FRAP and bind the lectin IB4. 
The other sub-class of DRG neurons which are still sensitive to NGF and express TrkA, contain 
neuropeptides such as CGRP and SP (Silos-Santiago et al., 1995). Non-peptidergic sensory 
neurons become sensitive to glial cell line-derived neurotrophic factor (GDNF) and express 
another receptor tyrosine kinase, Ret (Molliver et al., 1997; Bennett et al., 1998). 
In summary, adult peptidergic PSNs are sensitive to NGF, express TrkA and co-express CGRP 
and SP, whereas the non-peptidergic sub-class of nociceptive sensory neurons are sensitive to 
GDNF, express RET, and co-express TMP/FRAP and bind the IB4 (Table 2). These two 
different sub-classes of B-type small to medium sized DRG neurons are nociceptive in function, 
and have a selective chemosensitivity for exogenous pungent agents, such as capsaicin and 
resiniferatoxin (RTX). The knowledge of the specific neurochemical features of nociceptive 
PSNs enables their morphological identification by using histochemical and 
immunohistochemical techniques of high sensitivity and specificity.   
 Peptidergic C-fibre PSNs Non-peptidergic C-fibre PSNs 
Peptide containing + – 
IB4-binding – + 
NGF-sensitivity + – 
GDNF-sensitivity – + 
TrkA expression + – 
RET expression – + 
Table 2. Neurochemical traits of sub-classes of adult C-fibre DRG neurons  
1.1.3. Capsaicin: a specific chemical tool in the study of nociceptive primary sensory neurons 
Capsaicin is the main, active, highly pungent constituent of chilli peppers which belongs to the 
genus Capsicum. Chemically, capsaicin is a naturally occurring alkaloid, a derivative of vanillyl 
amide, 8-methyl-N-vanillyl-6-nonenamide. It is now well-known that it evokes a burning pain 
sensation and, following repeated local or systemic applications, produces long-lasting 
unresponsiveness of the skin or mucous membranes to noxious chemical stimuli (Jancsó, 1960, 
1968). Allegedly, this effect of chillies has been exploited by Aztecs and Inca’s for controlling 
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burning pain. Christopher Friedrich Bucholz was the first who extracted capsaicin in impure 
form in 1816 (Bucholz, 1816). Later, the Hungarian scientist, Endre Hőgyes suggested that the 
irritant effect of Capsicum extracts is mediated by sensory nerves (Hőgyes, 1878). Lastly, the 
chemical structure of capsaicin has been determined by E.K. Nelson and L.E. Dawson in 1923 
(Nelson and Dawson, 1923). 
In the second half of the 20th century, N. Jancsó discovered that local or systemic 
administrations of capsaicin at high concentrations produced insensitivity of the experimental 
animals to painful stimuli induced by chemical irritants, but not by mechanical stimuli. Since 
then, the term "capsaicin desensitization" is used to describe this phenomenon (Porszász and 
Jancsó, 1959; Jancsó, 1960, 1968; Jancsó et al., 1967). Jancsó also observed that local 
application of capsaicin and mustard oil (allyl-isothiocyanate) onto the skin produces not only 
burning pain, but local vascular reactions such as vasodilation and plasma extravasation in rats. 
This observation suggested that the role of capsaicin sensitive sensory fibres may be more 
complex than merely the transmission of nociceptive stimuli. It has been revealed that these 
nerves have a dual function: on the one hand, they convey nociceptive impulses toward the 
CNS (sensory afferent function), and on the other hand, they play a crucial role in local vascular 
responses (sensory efferent or local regulatory function) i.e. in neurogenic inflammation 
(Jancsó, 1960).  
The morphological and additional functional characteristics of capsaicin-sensitive PSNs have 
been revealed by Gábor Jancsó and his colleagues. Jancsó and his colleagues (1977) have 
observed that systemic administration of capsaicin to new-born rats results in a selective 
degeneration of a morphologically, neurochemically and functionally unique sub-class of 
somatic and visceral PSNs in DRGs and in cranial sensory ganglia (Jancsó et al., 1977). 
Detailed morphological studies using histological techniques to detect axon terminal 
degeneration have revealed the CNS distribution of chemosensitive/nociceptive primary 
afferents in several animal species (Jancsó and Király, 1980). Neonatal capsaicin treatment by 
producing degeneration of chemosensitive PSNs results in a permanent abolition of the 
neurogenic inflammatory response (Jancsó et al., 1977; Jancsó et al, 1980). It has also been 
revealed that capsaicin-sensitive nerves participate in the transmission of impulses evoked by 
noxious heat (Jancsó et al., 1980, 1987). Making use of the selective neurodegenerative action 
of capsaicin on chemosensitive PSNs, the morphological, functional and neurochemical 
characteristics and significance of this unique sub-class of nociceptive PSNs has been revealed.  
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In the early 1990s, studies on the effect of RTX in Peter Blumberg's laboratory have provided 
evidence for the existence of a specific receptor for capsaicin. Szállási and Blumberg have 
described that a homovanillic acid ester, RTX, the ingredient of Euphorbia resinifera, shows 
analogy with capsaicin and may be regarded as an ultrapotent analogue of it (Table 3). The 
binding characteristics of the receptor and its distribution within the nervous system have been 
described in detail by Árpád Szállási and his colleagues (Szállási and Blumberg, 1990; Szállási 
et al., 1994). They have suggested that the capsaicin receptor is sensitive to molecules 
structurally related to vanilloids; henceforth the capsaicin-receptor was named the “vanilloid 
receptor”.  
In the late 1990s, Michael J. Caterina and his colleagues have identified an ion channel, which 
resembled transient receptor potential ion channels discovered in the eye of a mutant fruit fly 
Drosophila melanogaster. This non-selective cation channel, termed the capsaicin or transient 
receptor potential vanilloid 1 receptor (TRPV1, Caterina et al., 1997) is specifically sensitive 
to capsaicin and related compounds, the vanilloids, and is also sensitive to intense heat. Hence, 
it was the first cloned thermal transducer sensitive molecule to noxious heat (> 43 oC) (cf. 
Tominaga et al., 1998). It has also been demonstrated that TRPV1 is selectively expressed in a 
subset of small-medium sized PSNs (Caterina et al., 1997). By developing TRPV1 knock-out 
mice, it has also been revealed that TRPV1 has a fundamental role in physiological and 
pathological processes associated with capsaicin-sensitive sensory nerves. Sequence analysis 
has revealed that TRPV1 is a member of the TRP receptor superfamily. The TRP receptor 
superfamily can be divided into seven subfamilies, and comprises more than 30 ion channels 
(Caterina et al., 1997; Guo et al., 2001; Nilius and Owsianik, 2011). The vanilloid, the ankyrin 
and the melastatin types are thermosensitive and play an important role in nociceptive 
transduction and neurogenic inflammation (Holzer, 1991; Uchida and Tominaga, 2011).  
The cloned form of the TRPV1 is predicted to have six transmembrane domains with an 
additional short, intramembrane stretch between the fifth and sixth transmembrane domains 
(Caterina et al., 1997). The functional form of the receptor consists of a tetramer of subunits. 
Both the N- and C-termini are localized intracellularly that acquire several regulatory features 
including various phosphorylation sequences for protein kinase A (PKA), protein kinase C 
(PKC), Ca2+/calmodulin dependent kinase II (CaMkII) and for phosphatidylinositol 
diphosphate (PiP2) (Montell, 2001). The capsaicin-binding site of the receptor is located 
intracellularly, and the activation by capsaicin or other vanilloids results in the influx of Ca2+ 
and Na+, thus the depolarization of the cell (Jung et al., 1999). The increase of intracellular Ca2+ 
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concentration in DRG neurons, which was shown in histochemical studies first by Jancsó and 
his colleagues following the administration of capsaicin to new-born rats, has a pivotal role in 
the exocytosis of neuropeptides from sensory nerve terminals, too (Jancsó et al., 1978). Further, 
the TRPV1 is permeable for Co2+ ions that has been utilized for in vitro histochemical 
identification of capsaicin-sensitive neurons (Hogan, 1983). 
Under physiological conditions, TRPV1 is activated by noxious heat (~ 43 °C), low pH, various 
lipids from the metabolism of arachidonic acid, protons and endogenous vanilloids, such as N-
oleoyldopamine, anandamide (arachidonoylethanolamide) and N-arachidonoyl dopamine (Di 
Marzo et al., 2001; Van Der Stelt and Di Marzo, 2004) (Table 3). 
Additionally, TRPV1 can be sensitized by various substances released upon tissue damage and 
the following inflammation (Julius and Basbaum, 2001). Bradykinin (Tang et al., 2004), 
histamine (Kim et al., 2004), ATP, prostaglandin E2 (Moriyama et al., 2005) and NGF 
(Bonnington and McNaughton, 2003) are the well-known agents which sensitize the TRPV1 
(Table 3). The molecular mechanisms of the sensitization involve the activation of guanyl 
nucleotide-binding protein (G-protein)-coupled receptors. G-protein-coupled receptors are 
connected to different signalling pathways involving PKA, PKC, phosphatidylinositol-3 kinase 
(PI3K), phospholipase C (PLC) and CaMkII. Moreover, it has been revealed that members of 
receptor tyrosine kinases such as insulin-like growth factor 1 (IGF-1) and insulin can also 
sensitize the TRPV1 (Sathianathan et al., 2003; Van Buren et al., 2005; Lilja et al., 2007) (Table 
3). 
1.2. Insulin and its possible role in the modulation of the function of TRPV1-expressing 
primary sensory neurons  
Recently, several studies have suggested that insulin, besides its pivotal role in body 
metabolism, has potential effects on PSNs. Insulin is the most potent anabolic polypeptide with 
a molecular mass of about 6000 Da secreted by the  cells of the islets of Langerhans in the 
form of a single chain of three peptides, and is critically involved in the regulation of 
carbohydrate, lipid and protein metabolism (Docherty and Steiner, 1982; Bliss, 1993). After its 
discovery in 1922 (Banting and Best, 1922), it has been revealed that under physiological 
conditions glucose is the most important agent which stimulates the pancreatic secretion of 
insulin (Chen and Porte, 1976). It is to be noted that in addition to insulin other endogenous 
factors such as growth hormones, adrenocorticosteroids, catecholamines, sensory 
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neuropeptides and neural stimuli may also modulate insulin's secretion (Bliss, 1993). The most 
important action of insulin is to promote the transport of blood glucose into insulin-dependent 
tissues such as the liver, muscle and adipose tissue by the regulation of glucose transporters 
(Bliss, 1993; Furtado et al., 2002). 
 Endogenous factors Exogenous factors 
Activators 
heat 
low pH 
arachidonic acid 
N-oleoyldopamine 
N-arachidonoyl dopamine 
capsaicin 
resiniferatoxin 
other vanillotoxins 
Inhibitors 
PIP2 
calmodulin 
capsazepine 
cinnamides 
carboxamides 
Sensitizers 
bradykinin 
prostaglandins 
NGF 
histamine 
ATP 
IGF-1 
insulin 
capsaicin 
resiniferatoxin 
other vanillotoxins 
Table 3. Exogenous and endogenous factors which activate, inhibit or sensitize the TRPV1 
nociceptive ion channel 
The biological effects of insulin are mediated by the insulin receptor (InsR), one of the first 
peptide receptor identified decades ago (Massague et al., 1980). The InsR is a heterotetrametric 
transmembrane receptor which belongs to the tyrosine kinase receptor superfamily. It consists 
of 2 extracellular  and 2 transmembrane glycoprotein  subunits linked by disulphide bonds 
(Kido et al., 2001). Insulin by binding to the  subunit, induces conformational changes of the 
intracellular component of the  subunit conferring the phosphorylation of tyrosine residues on 
intracellular substrates such as insulin receptor substrate (IRS) proteins (Saltiel and Pessin, 
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2003). Upon phosphorylation, IRS proteins can bind other signalling molecules containing src-
homology-2 domain proteins, which include PI3K and growth factor receptor bound protein 2 
(GRB2)/son of sevenless (SOS) protein (Waters et al., 1995; White, 2006). IRS proteins show 
a different tissue distribution and physiological effect, e.g. IRS-1 is the major IRS in the skeletal 
muscle and involved in the mitogenic effects of insulin, while IRS-2 is responsible for the 
mediation of growth of  cells and peripheral actions of insulin (White, 2006).  
Signalling pathways of insulin involves the PI3K and the Grb2/SOS signalling mediators. PI3K 
increases lipid and protein synthesis and the translocation of glucose transporters by regulating 
the protein kinase B (Akt) and PKC. Grb2/SOS is linked to the rat sarcoma protein which 
activates the mitogen activated protein kinase (MAPK)/extracellular signal regulated kinases 
(ERK) cascades. The MAPK/ERK pathway is related to proliferation and cell growth.  
After identification of the InsR, morphological studies focused on its tissue distribution. Earlier 
studies by using a radiolabelling technique have revealed that InsR exists on the membrane of 
all mammalian cells, however, with a different distribution pattern (Bergeron et al., 1980; 
Gammeltoft, 1984; Whitcomb et al., 1985; Watanabe et al., 1992). In vivo studies demonstrated 
high specific binding of intravenously injected I25I-insulin in the liver, the pancreas, the 
intestines and the blood vessels of the skeletal muscles (Bergeron et al., 1980; Gammeltoft, 
1984; Whitcomb et al., 1985; Watanabe et al., 1992).  
Several studies by using in vitro autoradiography demonstrated the presence of InsRs in the 
brain (Baskin et al., 1986; Hill et al., 1986; Werther et al., 1987). Moreover, the presence of the 
InsR mRNA has also been demonstrated in the rat brain (Marks et al., 1990). Other studies 
demonstrated the presence of InsRs in the olfactory bulb, cerebellum, hippocampus and in the 
hypothalamus. These findings have also been supported by immunohistochemical studies 
demonstrating the localization of InsRs in those brain areas (Havrankova et al., 1978; Pacold 
and Blackard, 1979).   
Besides its pivotal role in the regulation of energy metabolism, insulin has been suggested to 
exert distinct effects on several neuronal systems. Insulin has been shown to increase uridine 
and leucine incorporation in cultured DRGs (Levi-Montalcini, 1966; Burnham et al., 1974), and 
CNS (Raizada et al., 1980). Ornithine decarboxylase activity is also enhanced by insulin in 
some regions of the CNS (Roger and Fellows, 1980). 
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Nevertheless, the first publications about the neural actions of insulin focused on its possible 
role in trophic processes in the peripheral nervous system. It has been revealed that insulin 
enhances neurite outgrowth in cultured human neuroblastoma cells in both serum-containing 
and serum free media (Recio-Pinto and Ishii, 1984). Further, insulin potentiates NGF’s action 
and increases NGF binding in rat pheochromocytoma PC12 cells which share characteristics 
with nociceptive PSNs (Recio-Pinto et al., 1984). In addition, administration of insulin at 
physiological concentrations promotes neurite outgrowth in cultured sympathetic and sensory 
neurons (Recio-Pinto et al., 1986a). Fernyhough and his colleagues have also demonstrated that 
cultured DRG neurons respond with an increased regenerative growth to insulin (Fernyhough 
et al., 1993). 
Immunohistochemical studies have supported these observations. Sugimoto and his colleagues 
have revealed by using immunohistochemistry and reverse transcription polymerase chain 
reaction that InsR is localized to the paranodal axolemma, the terminal Schwann cell loops, the 
Schmidt-Lantermann incisures and pericytes in rat myelinated peripheral nerve fibres 
(Sugimoto et al., 2000). It has also been demonstrated that InsR is expressed in small-sized 
sensory DRG neurons and in lateral lamina V and in  lamina X of the spinal cord suggesting 
the role of InsRs and insulin in nociception (Sugimoto et al., 2002). 
The mechanisms of the neurotrophic actions of insulin on PSNs may involve several 
mechanisms, but the pivotal significance of the InsRs was recognized. For example, DRG 
neurons develop resistance to the neurite outgrowth-promoting effects of micromolar 
concentrations of insulin through the desensitization of the InsRs and the inhibition of the 
PI3/Akt pathway (Singh et al., 2012). However, administration of insulin at nanomolar 
concentrations by activating the PI3-Akt pathway (Huang et al., 2005; Singh et al., 2012) 
increases neurite outgrowth of cultured DRG neurons. Nonetheless, the neurite-outgrowth 
promoting action of insulin on DRG neurons involves other mechanisms as well, such as the 
stabilization of tubulin which is essential in neurite formation (Fernyhough et al., 1989). It has 
also been shown that activation by insulin of TrkA expressed by peptidergic nociceptive 
sensory neurons, also plays an important role in insulin’s neurite outgrowth promoting effects 
(Geetha et al., 2013).   
The view that insulin exerts trophic actions on peripheral nerves has received extensive support 
by recent in vivo findings which showed that systemic (Xu et al., 2004) and intrathecal (Toth et 
al., 2006) administration of insulin prevents degenerative changes of motor and sensory fibres 
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after axonal injuries. Grote and his colleagues have demonstrated that DRG neurons and 
peripheral nerves are insulin responsive in vivo (Grote et al., 2013). Considering the potent 
neurotrophic qualities of insulin on sensory nerves, in recent years several studies have focused 
on its possible role in the pathogenesis of diabetic neuropathy as well. It has been demonstrated 
that insulin signalling in DRG neurons from diabetic mice shows similarities to insulin 
resistance related to muscle and adipose tissues (Grote et al., 2011). 
Collectively, available experimental data indicate that neural actions of insulin are mediated by 
multiple signalling pathways involved in various physiological and pathophysiological 
processes. Importantly, the possible role of insulin in the modulation of (patho)physiological 
processes affecting somatosensory mechanisms, in particular those implicated in the mediation 
of pain, has been well established. 
The expression patterns of the TRPV1 and the InsR in small-sized DRG neurons have been 
revealed in immunohistochemical studies (Ahluwalia et al., 2000; Sugimoto et al., 2002).  
Further, it has been hypothesized that insulin may modulate the opening of the TRPV1 ion 
channel. Sathianatan and his colleagues observed that administration of insulin induces cobalt-
uptake of small-medium sized DRG neurons in a concentration-dependent manner, and co-
application of capsaicin with insulin potentiates the capsaicin-evoked cobalt-labelling of DRG 
neurons (Sathianathan et al., 2003). Similarities of the signalling pathways of the InsR and the 
TRPV1 have also been revealed (Heidenreich et al., 1990; Kayali et al., 1998; Cesare et al., 
1999). Hence, the insulin-induced activation of DRG neurons is significantly reduced by the 
tyrosine kinase inhibitor, tyrphostin and the PLC inhibitor, neomycin, and by TRPV1 
antagonists (Sathianathan et al., 2003). It has been revealed that about 30% of DRG neurons 
co-express the InsR and the TRPV1. Further experiments revealed that insulin enhances 
TRPV1-mediated membrane currents of cultured DRG neurons by triggering the PI3K and PKC 
pathways, resulting in sensitization of TRPV1 (Van Buren et al., 2005). Lilja and his colleagues 
also demonstrated that long-term insulin exposure increases TRPV1 protein expression by 
regulating the PI3K and MAPK/ERK signalling pathways (Lilja et al., 2007).  
These findings have received extensive support by in vitro immunohistochemical findings. 
Baiou and his colleagues showed that InsR-immunoreactive (IR) mouse DRG neurons are 
small-medium sized, which are considered as nociceptive neurons, and display a relatively high 
co-expression with TRPV1, CGRP and IB4 (Baiou et al., 2007). Our recent observations 
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supported these findings, by showing that InsR is co-localized with TRPV1, CGRP and IB4 in 
cultured adult rat DRG neurons (Lázár et al., 2018). 
1.3. The role of nociceptive primary sensory nerves in pathological conditions 
In the last few decades, the participation of the TRPV1-expressing nociceptive somatic and 
visceral PSNs has been demonstrated in a variety of physiological and pathological processes. 
Extensive work has been done on the role of TRPV1-expressing chemosensitive PSNs in 
mechanisms of pain and inflammation. Importantly, it has been recognized that chemosensitive 
PSNs participate not only in mechanisms of physiological (nociceptive) and pathological 
(neuropathic) pain but are also implicated in a variety of physiological processes including inter 
alia vascular reactions, smooth muscle contraction/relaxation, cardiac function, glandular 
secretion, and endocrine regulation (Holzer, 1988; Maggi and Meli, 1988). Pharmacological, 
neurochemical and immunohistochemical studies have revealed that many of these sensory-
efferent or local regulatory functions of chemosensitive PSNs are mediated by neuropeptides 
released from the stimulated sensory nerve endings. Hence, the dual functional character of 
chemosensitive PSNs, first envisaged and proved by N. Jancsó (Jancsó, 1960; Jancsó et al., 
1968) has been amply confirmed and supported by a vast body of experimental data (for reviews 
see Holzer, 1988; Maggi and Meli, 1988; Szolcsányi, 1996; Nagy et al., 2004; Jancsó et al., 
2009).  
It is beyond the scope of this Thesis to give an even superficial account on the role of 
chemosensitive PSNs in the function of different tissues and organs. However, a brief survey 
of the most important functional features of chemosensitive PSNs innervating some somatic 
and visceral organs/tissues seems to be appropriate in order to understand the similarities and 
dissimilarities of the morpho-functional traits of PSNs innervating the different organs.                       
TRPV1-expressing cutaneous sensory fibres have a pivotal role in the pathologies related to the 
skin. The epidermis is almost exclusively innervated by capsaicin-sensitive TRPV1-expressing, 
in part peptidergic sensory nerves. Hence, perineural application of capsaicin almost completely 
eliminated both chemical pain sensation and the fine intraepidermal nerve fibres in the rat skin. 
It has been shown that perineural capsaicin treatment resulted in a loss of about 80% of 
epidermal and about 30% of all cutaneous sensory fibres (Jancsó and Lawson, 1990; Pini et al., 
1990; Dux and Jancsó, 1994). Besides nociception, these sensory nerves, by releasing sensory 
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neuropeptides, are key players of inflammatory changes, including both neurogenic and non-
neurogenic inflammatory processes (Jancsó, 1960; Jancsó et al., 1980, 1985).  
The significant contribution of TRPV1-immunopositive sensory fibres to the development of 
urinary bladder dysfunction is well-established. Classical hodological studies have revealed that 
the urinary bladder is innervated by capsaicin-sensitive sensory nerves from Th13-L3 and L6-S1 
DRGs, and capsaicin-sensitive urinary bladder primary afferents terminate in laminae I, V and 
X (Jancsó and Maggi, 1987; Gabella and Davis, 1998). The TRPV1-expression of epithelial 
and urothelial cells of the bladder has also been revealed in the rat (Birder et al., 2001; Avelino 
et al., 2002) and in man (Lazzeri et al., 2004) as well. The contribution of capsaicin-sensitive 
sensory nerves in the inflammatory changes of the urinary bladder has been reported decades 
ago (Maggi et al., 1993). Direct and indirect activation of TRPV1-expressing bladder afferents 
have been implicated in the mechanisms of the micturition reflex (Quartara and Maggi, 1998; 
Birder et al., 2001). Furthermore, activation/sensitisation of TRPV1 plays an important role in 
the development of urinary bladder disorders including acute cystitis, painful bladder syndrome 
and overactive bladder (Avelino and Cruz, 2006). Recent findings have also revealed that 
intravesical administration of TRPV1 agonists capsaicin or RTX increases bladder capacity of 
the chronically inflamed rat bladder suggesting a significant role of chemosensitive afferents in 
bladder pain and inflammation (Dinis et al., 2004a). Although the roles of the TRPV1-
expressing nerves and the endogenous ligands of the TRPV1 receptor are not fully understand 
in bladder dysfunctions, intravesical administration of TRPV1 agonists proved to be 
therapeutically beneficial in various pathologies of the urinary tract (Maggi et al., 1993; 
Yiangou et al., 2001).  
Chemosensitive afferent nerves also play an important role in gastrointestinal physiology and 
pathology. Motility, secretion, endocrine and immune functions are all affected by extrinsic 
nerves of the gastrointestinal tract, which are comprised to a significant extent of 
chemosensitive afferent nerves (cf. Barthó and Szolcsányi, 1978; Barthó et al., 2004, 2008). 
Retrograde labelling studies by Sharkey and his colleagues (Sharkey et al., 1984) provided 
evidence for the innervation of the pancreas by capsaicin-sensitive peptidergic PSNs. Sharkey 
and his colleagues by using retrograde tracing technique and immunohistochemistry have 
revealed that rat pancreas is innervated by capsaicin-sensitive sensory neurons from the Th6-L2 
DRGs and the nodose ganglia (NGs). After neonatal capsaicin treatment, SP-IR fibres 
innervated the rat pancreas is also depleted (Sharkey and Williams, 1983; Sharkey et al., 1984). 
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These findings have been supported by W. L. Neuhuber who described that vagal afferent fibres 
exclusively innervate the islets of Langerhans in rats by using anterograde tracing method 
(Neuhuber, 1989).  
In the recent years, several studies have suggested that neurogenic inflammation mediated by 
peptidergic TRPV1-positive nociceptive PSNs plays an important role in the pathogenesis of 
acute and chronic pancreatitis. Nathan and his colleagues have demonstrated that TRPV1 
antagonist, capsazepine reduces the level of neurokinin-1 receptor (NK1R), the receptor of SP, 
the pancreatic enzymes associated with pancreatitis and the severity of histological changes of 
pancreas during caerulein-induced experimental pancreatitis in mice. Furthermore, it has also 
been revealed that rat pancreatic acini are innervated by TRPV1-immunopositive sensory fibres 
which contain SP and CGRP. Other studies have showed that mRNA expression of TRPV1 is 
increased in rat thoracic DRG neurons after trinitrobenzene sulfonic acid induced chronic 
pancreatitis. 
TRPV1 is also expressed in islets of Langerhans, and it has been demonstrated that TRPV1 
modulates the insulin secretion of the beta cells (Akiba et al., 2004).  The direct effect of sensory 
neuropeptides on beta cells has also been shown (Hermansen and Ahren, 1990; Barakat et al., 
1994; Ahren, 2000; Razavi et al., 2006). Razavi and his colleagues have revealed that by using 
immunohistochemistry, islets of Langerhans are innervated by a meshwork of TRPV1-positive 
fibres, and these fibres are eliminated by neonatal capsaicin treatment in non-obese diabetic 
(NOD) mice, an experimental model of type 1 diabetes mellitus. Other working groups have 
showed that CGRP-expressing fibres which innervate the rat islets of Langerhans also express 
the TRPV1. Systemic administration of capsaicin prevents the development of glucose 
tolerance and hyperinsulinemia in Zucker diabetic fatty (ZDF) rats, an animal model of human 
type 2 diabetes (Gram et al., 2007). Additionally, the contribution of TRPV1-positive C-fibres 
in pancreatic tumour development has also been shown (Hartel 2006, Saloman, 2016). 
1.4. Retrograde axonal tract tracing methods for the identification of primary sensory neurons 
innervating specific organs 
Although identification of PSNs innervating different organs/tissues has some morphological, 
histological and functional difficulties, axonal tract tracing of neuronal pathways introduced in 
the early 1970's allows a precise identification of sensory and motor circuits. 
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Axonal transport is essential in the intraneuronal movement of a variety of substances such as 
synaptic vesicles, membranous organelles, lipids, proteins and bacterial toxins. The axonal 
transport is crucial in the communication between the perikarya and the nerve ending. This 
process is regulated by cytoskeletal components of the axon including neurotubuli and motor 
proteins (kinesin, dynein). There are two types of axonal transport processes: anterograde or 
cellulifugal transport directed from the cell body to the nerve terminals, and retrograde or 
cellulipetal transport directed from the nerve terminals towards the cell body. Over the past few 
decades, neuroanatomical tract tracing methods based on axonal transport of various tracers 
have led to the identification of PSNs which innervate specific organs/tissues. Injection of 
specific tracer molecules into the selected tissues/organs allows the identification of the parent 
cell bodies of PSNs innervating the selected tissue/organ. Identified PSNs may be further 
characterized by determining their size and chemical phenotypes using morphometric, 
histochemical and immunohistochemical techniques.   
Horseradish peroxidise (HRP) is a widely used non-selective retrograde tracer for the 
identification of different (unmyelinated and myelinated) types of PSNs (Molander and Grant, 
1985, 1987). HRP is a non-selective tracer, hence, HRP is unsuitable for the selective 
identification of different sub-classes of PSNs. However, HRP conjugated with specific lectins, 
such as wheat germ agglutinin (WGA) or with cholera toxin B subunit is specifically taken up 
and transported by unmyelinated and myelinated afferent axons resulting specific labelling of 
the different populations of DRG.  
Distinct sub-classes of PSNs express glycoconjugates with specific carbohydrate epitopes 
which show affinity for lectins. Small-medium sized capsaicin-sensitive DRG neurons show 
reactivity for specific lectins. For example, the lectin, WGA specifically binds to N-acetyl 
glucosamine residues of the carbohydrate chains of glycoconjugates of the plasma membrane 
(Sharon and Lis, 1972; Macsween and Fox, 1975). Available literature data unequivocally 
indicate that WGA is a specific lectin bound by small-medium sized nociceptive PSNs 
(Robertson and Arvidsson, 1985; Robertson, 1990; Oszlács et al., 2015). However, for the use 
of lectins as retrograde tracers, it is indispensable to conjugate them to specific tracers. It has 
been revealed that injection of WGA conjugated with biotin, fluorophore or HRP into peripheral 
organs results in a selective labelling of unmyelinated small-medium sized nociceptive PSNs 
(LaMotte and Campbell, 1978; Robertson and Arvidsson, 1985; Robertson, 1990). Therefore, 
in the present study WGA conjugated with biotin was used for the retrograde labelling of C-
fibre PSNs innervating the targeted organs. 
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2. AIMS OF THE STUDY 
Previous observations demonstrated a functional interaction between the InsR and the TRPV1 
in vitro, and a substantial co-localization of the InsR with the TRPV1 in rat and mouse native 
dorsal root ganglion (DRG) neurons. Although these studies have provided clear evidence for 
the localization and functionality of the InsR in PSNs, information is not available as to the 
target specificity of InsR-positive PSNs. The exploration of the target organs innervated by 
PSNs which express the InsR is of critical importance for the understanding of the possible role 
of the InsR in the mechanism of physiological and pathological processes.  
Therefore, the principal aim of the present Thesis was the morphometric and neurochemical 
characterization of InsR-expressing nociceptive PSNs innervating somatic (skin and skeletal 
muscle) and visceral (pancreas and urinary bladder) organs with particular emphasis on the co-
localization of the InsR with TRPV1 by using retrograde neuronal tracing techniques combined 
with quantitative morphometry and immunohistochemistry.  
Recent observations indicated that an interplay among insulin, the sensory neuropeptides SP 
and CGRP and pancreatic PSNs which express the nociceptive ion channel TRPV1 may 
significantly contribute to pathological processes affecting both the exocrine and the endocrine 
pancreas. Therefore, an additional aim of the present Thesis was the further phenotypic 
characterization of pancreatic nociceptive DRG and NG neurons by using quantitative 
morphometric and immunohistochemical techniques to demonstrate the expression and co-
expression patterns of the InsR, TRPV1, SP and CGRP. 
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3. MATERIALS AND METHODS 
3.1. Experimental animals 
Adult male Wistar rats (n=17) weighing 300-350 g were used in this study. All experiments 
were approved by the Ethics Committee for Animal Care at the University of Szeged and were 
carried out in full accordance with the Directive 2010/63/EU of the European Parliament and 
of the Council on the Protection of Animals Used for Scientific Purposes and the guidelines of 
the Committee for Research. All efforts were made to minimize animal suffering. The number 
of experimental animals was kept as low as possible. 
3.2. Surgery and retrograde neuronal labelling 
The rats were anesthetized with chloral hydrate (400 mg/kg, intraperitoneally; Reanal, 
Budapest, Hungary) or with isoflurane (ForeneTM, AbbVie Hungary Ltd., Budapest, Hungary). 
For the identification of spinal cutaneous, muscle, urinary bladder, and spinal and vagal 
pancreatic PSNs, biotin-conjugated wheat germ agglutinin (bWGA; Sigma-Aldrich, 
Gillingham, UK, 1% in distilled water) was injected into the target organ using a Hamilton 
microsyringe. To identify cutaneous PSNs, 2x2 µls of the bWGA solution were injected into 
the dorsal hind paw skin. For labelling of muscle spinal PSNs, the gastrocnemius muscle was 
exposed through an incision at the dorsal aspect of the calf and 2x2 µls of the bWGA solution 
were injected into the muscle. To label PSNs innervating the urinary bladder or the pancreas, 
the abdominal cavity was opened through a midline incision, the organs to be injected were 
carefully exposed and 4x2 µls of the bWGA solution were injected into the wall of the urinary 
bladder or the head, the body and the tail of the pancreas. Thereafter, the exposed areas were 
thoroughly rinsed with saline and the abdominal wall was closed in layers. After recovery from 
anaesthesia, the rats were returned to the animal house. 
3.3. Histological methods 
3.3.1. Tissue preparation and sectioning 
Three days after the injection of bWGA, the rats were terminally anesthetized with an overdose 
of thiopental sodium (Insera Arzneimittel GmbH, Freiburg, Germany; 150 mg/kg i.p.) and were 
perfused transcardially first with physiological saline (100 ml), immediately followed by a 
fixative containing 4% paraformaldehyde in 0.1 M phosphate buffer (pH 7.4).  To examine 
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neurons retrogradely labelled from the dorsal hind paw skin, the gastrocnemius muscle, the 
urinary bladder and the pancreas, the L3-L5 (Gamse et al., 1982; Swett et al., 1991), L4-5 
(Peyronnard et al., 1986; Swett et al., 1991), L3-S1 (Jancsó and Maggi, 1987) and Th10-13 (Won 
et al., 1998; Takamido et al., 2006) DRGs, respectively were removed on both sides. In the case 
of the pancreas, the right and left NGs were also removed. The samples were post-fixed for 2 h 
and stored in 0.1 M phosphate buffer (pH 7.4) containing 30% sucrose at 4°C until sectioning. 
Serial frozen sections of the DRGs and the NGs, 15 µm in thickness, were cut on a cryostat. 
3.3.2. Lectin- and immunohistochemistry 
Sections were rinsed twice for 10 minutes in phosphate-buffered (0.01 M) isotonic NaCl 
solution (phosphate-buffered saline, PBS), and incubated in PBS containing 1% donkey serum 
and 0.1% Triton X-100 for 12 hours and processed for staining with the indirect 
immunofluorescence technique using the following antibodies: rabbit anti-InsRα subunit 
antibody (Santa Cruz Biotechnologies, Dallas,  Tex., USA; 1:500, ), guinea pig anti-TRPV1 
antibody (Neuromics, Edina, Minn., USA; 1:1500), mouse anti-CGRP antibody (Abcam, 
Cambridge, UK; 1:1500), and guinea pig anti-SP antibody (Abcam, 1:1500). Donkey anti-
rabbit IgG labelled with DL488 (1:500), donkey anti-guinea pig IgG labelled with Cy3 (1:500) 
and donkey anti-mouse IgG labelled with Cy3 (1:500) were used as secondary antibodies (all 
from Jackson Immunoresearch Laboratories, West Grove, Pa., USA). bWGA lectin was 
detected by using an extravidine-AMCA conjugate (Jackson Immunoresearch Laboratories).  
All antibodies were diluted in PBS containing 0.3% Triton-X-100. Sections were incubated in 
the presence of the primary antibodies overnight at 4°C and, after washing with PBS for 3x10 
min, incubated for 2 hours with the secondary antibodies. Control procedures for 
immunolabelling were performed by replacing the primary antisera with normal donkey serum. 
No immunostaining was observed in control experiments. For fluorescence microscopy, the 
specimens were covered with Prolong Gold antifade mounting medium (Invitrogen, Carlsbad, 
Calif., USA).  
3.4. Data analysis 
DRG and NG neurons with clear-cut nuclei were selected and analysed in systemic random 
serial photomicrographs taken with a Leica DMLB fluorescence microscope (Wetzlar, 
Germany) under x40 magnification, equipped with a Retiga 2000R digital camera (QImaging, 
Surrey, B.C., Canada) connected to a computer running the ImagePro Plus 6 analysis software 
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(Media Cybernetics, Inc.; Rockville, Md., USA). Random serial images were captured from 
each selected sections of the ganglia.   
bWGA-positive neurons with visible nuclei were selected and analysis of retrogradely labelled 
neurons was performed by using the ImageJ (NIH; Bethesda, Md., USA; IJ1.46r) image 
analysis software. The mean cross-sectional areas of the total and the labelled populations were 
determined. Size-frequency distribution histograms were created by using the ImageJ (NIH) 
software.  
The relative proportions of the retrogradely labelled and InsR-, TRPV1-, CGRP- or SP-IR DRG 
and NG neurons were calculated in each ganglion, and pie charts and tables were generated. 
All data are presented as mean ± standard deviation (SD). Statistical comparisons of the data 
were performed using the Fisher’s exact probability test utilizing the Dell Statistica software 
(Dell Inc.; Tulsa, Okla., USA). A p value of ≤0.05 was considered as a statistically significant 
difference between groups.  
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4. RESULTS 
4.1. Retrograde labelling of DRG and NG neurons innervating somatic (skin, muscle) and 
visceral (urinary bladder, pancreas) organs  
After the injection of retrograde tracer into the target organs, the tracer is rapidly taken up and 
transported centripetally within a few hours to the parent cell bodies of PSNs. In this study, by 
using bWGA as a retrograde tracer, we identified numerous PSNs in the DRGs and NGs relating 
to the injected organ. Our findings showed that PSNs retrogradely labelled with bWGA 
belonged to the small to medium sized populations of DRG and NG neurons. 
Injection of bWGA into the dorsal hind paw skin resulted in the labelling of numerous neurons 
in the L3-L5 DRGs with a peak at L4 DRGs on both sides. 147 DRG neurons innervating the 
dorsal hind paw skin were identified and analysed from three animals. Fig. 1A illustrates 
retrogradely labelled cutaneous DRG neurons in the left L4 DRG. Analysis of size-frequency 
distribution histograms revealed that the mean cross-sectional area of the retrogradely labelled 
neurons amounted to 311.143.4 µm2 (Fig. 2A).  
Quantitative analysis revealed that after the injection of bWGA into the gastrocnemius muscle, 
138 neurons were retrogradely labelled in the L4-5 DRGs with a peak at L5 DRGs on both sides 
from three animals. Photomicrograph in Fig. 1B illustrates neurons in the right L4 DRG 
retrogradely labelled with bWGA from the gastrocnemius muscle. The mean cross-sectional 
area of the retrogradely labelled DRG neurons amounted to 345.855.9 µm2 (Fig. 2B).  
Injection of the retrograde tracer, bWGA into the wall of the urinary bladder resulted in the 
labelling of a great number of neurons in the L3-S1 DRGs with a peak at L6 DRGs on both sides 
(Fig. 1C). We identified and analysed 225 retrogradely labelled DRG neurons from four 
animals. Quantitative morphometry revealed that the mean cross-sectional area of the 
retrogradely labelled DRG neurons amounted to 339.254.8 µm2 (Fig. 2C).  
The DRG and NG neurons innervating the pancreas were identified by multiple injections of 
bWGA into the head, body and tail of the pancreas. Numerous retrogradely labelled neurons 
were found in the Th9-L1 DRGs on both sides with a peak in Th11, and in the left and right NGs. 
Fig. 1D and E illustrate pancreatic retrogradely labelled DRG (Fig. 1D) and NG (Fig. 1E) 
neurons in the left Th11 DRG and the right NG. Quantitative analysis revealed that 263 and 167 
neurons were retrogradely labelled with bWGA in the DRGs and NGs from four animals. The 
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analysis of the size frequency distribution of the retrogradely labelled DRG and NG neurons 
revealed that these neurons are small to medium sized with mean cross-sectional areas of 
447.239.4 µm2 and 585.444.9 µm2, respectively (Fig. 2D, E).  
Figure 1. Photomicrographs illustrating retrogradely labelled DRG and NG neurons after 
injections of bWGA into the skin, the gastrocnemius muscle, the urinary bladder and the 
pancreas. DRG neurons innervating the dorsal hind paw skin (A), the gastrocnemius muscle 
(B), the urinary bladder (C) and the pancreas (D, E) show bWGA-labelling in the L4 (A), the 
L5 (B), the L6 (C), the Th11 (D) DRGs and in the right NG (E).  The scale bar indicates 100 µm 
and applies to all photomicrographs.  
4.2. Expression of TRPV1 in identified somatic and visceral primary sensory neurons 
The large majority of bWGA-labelled cutaneous, muscle, urinary bladder and pancreatic DRG 
and pancreatic NG neurons showed TRPV1 immunoreactivity. Fig. 3. illustrates retrogradely 
labelled DRG and NG neurons which are IR for TRPV1. 
In the DRGs, 63.1±3.4% 62.5±2.7%, 65.0±1.8% and 68.2±4.8% of the retrogradely labelled 
neurons innervating the dorsal hind paw skin, the gastrocnemius muscle, the urinary bladder 
and the pancreas displayed TRPV1 immunoreactivity (Fig. 4). In the NGs, 64.0±3.9% of the 
identified pancreatic neurons showed TRPV1 immunopositivity (Fig. 4).   
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Figure 2. Size-frequency distribution histograms of dorsal root ganglion and nodose ganglion 
neurons retrogradely labelled with biotin-conjugated wheat germ agglutinin from the dorsal 
hind paw skin (A), the gastrocnemius muscle (B), the urinary bladder (C) and the pancreas (D, 
E). 
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Figure 3. Photomicrographs illustrating retrogradely labelled DRG and NG neurons after 
injections of bWGA into the skin, the gastrocnemius muscle, the urinary bladder and the 
pancreas, which display immunoreactivities for the InsR and the TRPV1. bWGA-labelled 
DRG and NG neurons innervating the dorsal hind paw skin (A, B, C), the gastrocnemius muscle 
(D, E, F), the urinary bladder (G, H, I) and the pancreas (J, K, L, M, N, O) showing 
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immunoreactivities for the InsR and the TRPV1 in the L4 (A, B, C), the L5 (D, E, F), the L6 (E, 
F, G), the Th11 (J, K, L) DRGs and in the left NG (M, N, O). The scale bar indicates 100 µm 
and applies to all photomicrographs.  
 
Figure 4. Pie charts show the relative proportions of the InsR- and the TRPV1-IR 
subpopulations of bWGA retrogradely labelled somatic and visceral DRG and NG 
neurons. Pie charts showing the percentage distributions and overlaps of bWGA-labelled InsR- 
and TRPV1-immunopositive DRG and NG neurons innervating the dorsal hind paw skin (A), 
the gastrocnemius muscle (B), the urinary bladder (C) and the pancreas (DRG 4D, NG 4E).  
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4.3. InsR expression in retrogradely labelled dorsal root ganglion and nodose ganglion 
neurons innervating the skin, skeletal muscle, the pancreas and the urinary bladder  
A relatively high proportion of DRG neurons labelled retrogradely with bWGA innervating the 
dorsal hind paw skin, the gastrocnemius muscle, the urinary bladder and the pancreas displayed 
InsR immunostaining. Similarly, many retrogradely labelled pancreatic NG neurons showed 
InsR immunoreactivity. These immunohistochemical findings are illustrated in Fig. 3.  
Our quantitative data indicate that 22.42.8% of cutaneous, 21.81.9% of muscle, 53.43.1% 
of urinary bladder, 48.32.6% of pancreatic DRG and 49.12.5% of pancreatic NG neurons 
displayed InsR immunoreactivity (Fig. 4). The statistical analysis revealed that there were no 
significant differences in the proportions of the InsR-IR neurons either between cutaneous and 
muscle DRG neurons or between pancreatic and urinary bladder spinal afferents. However, a 
highly significant difference between the proportions of the InsR-IR somatic and visceral DRG 
neurons was revealed (p < 0.05). 
4.4. Co-localization of the InsR with the TRPV1 in retrogradely labelled somatic and visceral 
dorsal root ganglion and nodose ganglion neurons 
To reveal the co-localization of the InsR with the TRPV1, the co-expression of the InsR and 
the TRPV1 in the bWGA-labelled DRG and NG neuron populations, the expression of the 
TRPV1 in the InsR-immunopositive bWGA-labelled DRG and NG neuron populations and the 
expression of the InsR in the TRPV1-immunopositive bWGA-labelled DRG and NG neuron 
populations were examined. The co-localization patterns of the InsR and the TRPV1 in 
retrogradely labelled DRG and NG neurons are illustrated in Fig. 3. 
First, the co-localization of the InsR with the TRPV1 was analysed in retrogradely labelled 
DRG and NG neurons. Our data indicated that 16.56±0.6% of cutaneous, 15.33±1.1% of 
muscle, 30.34±2.1±% of urinary bladder, 23.2±2.2% of pancreatic DRG and 35.3±1.7 of 
pancreatic NG neurons displayed both InsR and TRPV1 immunoreactivity, respectively (Fig. 
4). The statistical analysis revealed that there were no significant differences between either the 
cutaneous and muscle or the urinary bladder and pancreatic DRG and NG neurons. However, 
there were significant differences in the proportions of the InsR- and TRPV1-IR neurons 
between the somatic and visceral PSNs (p < 0.05). 
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The proportions of the TRPV1-immunopositive neurons in the bWGA-labelled InsR-IR neuron 
population were also assessed. 72.7±3.4%, 73.3±2.6%, 57.1±3.6%, and 50.1±3.0% of the 
bWGA-labelled InsR-IR DRG neurons innervating the dorsal hind paw skin, the gastrocnemius 
muscle, the urinary bladder and the pancreas displayed TRPV1 immunoreactivity, respectively 
(Table 1). Furthermore, our data indicate that 71.0±5.0% of the bWGA-labelled InsR-IR 
pancreatic NG neurons showed TRPV1-immunoreactivity. The statistical analysis revealed that 
there were no significant differences in TRPV1 expression among the five different populations 
of neurons. 
The expression of the InsR in the retrogradely labelled TRPV1-immunopositive DRG and NG 
neuron populations was also revealed. In the DRGs, 25.8±2.2%, 25.5±2.4%, 43.9±2.3% and 
34.0±1.96% of the bWGA-labelled TRPV1-IR neurons innervating the dorsal hind paw skin, 
the gastrocnemius muscle, the urinary bladder and the pancreas showed InsR-
immunoreactivity, respectively (Table 2). Of the bWGA retrogradely labelled TRPV1-IR 
pancreatic NG neurons, 55.4±2.0% showed InsR immunoreactivity. The statistical analysis 
revealed that there were no significant differences in the proportions of the InsR-IR neurons 
between either the cutaneous and the muscle DRG neurons or between the pancreatic DRG and 
NG and the urinary bladder DRG neurons. However, the differences between the cutaneous and 
pancreatic DRG neurons, the cutaneous and bladder DRG neurons, the muscle and pancreatic 
DRG neurons and the muscle and urinary bladder DRG neurons were significant (p < 0.05).  
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Table 1. Proportions of InsR-IR retrogradely labelled cutaneous, muscle, urinary bladder and 
pancreatic DRG and pancreatic NG neurons which express the TRPV1.  
Target organ (origin) 
TRPV1+ neurons (%) 
dorsal hind paw skin (DRG) 72.73.4 
gastrocnemius muscle (DRG) 73.32.6 
urinary bladder (DRG) 57.13.6 
pancreas (DRG) 50.13.0 
pancreas (NG) 71.05.0 
Table 2. Proportions of TRPV1-IR retrogradely labelled cutaneous, muscle, urinary bladder 
and pancreatic DRG and pancreatic NG neurons which express the InsR.  
Target organ (origin) 
InsR+ neurons (%) 
dorsal hind paw skin (DRG) 25.82.2 
gastrocnemius muscle (DRG) 25.52.4 
urinary bladder (DRG) 43.92.3 
pancreas (DRG) 34.01.96 
pancreas (NG) 55.42.0 
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4.5. Co-localization of the InsR with sensory neuropeptides (substance P and calcitonin gene-
related peptide) in pancreatic dorsal root ganglion and nodose ganglion neurons 
Considering the importance of sensory neuropeptides and the possible role of insulin and the 
InsR in pathologies of the pancreas, the co-localization patterns of the InsR, CGRP and SP, 
were analysed in pancreatic DRG and NG neurons. Examples of the co-localization pattern of 
the InsR with SP and CGRP are illustrated in Fig. 5. 
Our data revealed that 33.2±3.7% and 54.3±4.4% of retrogradely labelled DRG neurons 
innervating the pancreas displayed SP and CGRP immunoreactivity. In the NGs, 40.0±2.1% 
and 25.1±2.9% of retrogradely labelled pancreatic neurons showed SP and CGRP 
immunoreactivity (Fig. 6).  
In the DRGs and the NG 14.4±1.2% and 24.2±1.0% of retrogradely labelled neurons showed 
InsR and SP co-localization (Fig. 6). Further, 28.4±1.3% and 46.21.9% of the retrogradely 
labelled pancreatic InsR-immunopositive DRG and NG neurons displayed SP 
immunoreactivity (Table 3). Conversely, 42.0±4.8% and 60.2±4.2% of the labelled SP-IR DRG 
and NG neurons were IR for the InsR (Table 4). 
The co-localization of the InsR with CGRP was also examined. Our data revealed that 
28.4±2.7% and 8.0±0.9% of the retrogradely labelled pancreatic DRG and NG neurons 
exhibited both InsR and CGRP immunoreactivity (Fig. 6). Further, of the retrogradely labelled 
InsR-immunopositive DRG and NG neurons, 58.3±5.3% and 17.4±3.6% displayed CGRP 
immunoreactivity (Table 3). Conversely, 52.1±4.4% and 32.0±2.5% of the retrogradely labelled 
pancreatic CGRP-IR DRG and NG neurons showed InsR immunopositivity (Table 5). 
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Figure 5. Photomicrographs showing bWGA-containing retrogradely labelled pancreatic 
DRG and NG neurons which display immunoreactivities for the InsR, SP and CGRP. 
bWGA-labelled DRG and NG neurons innervating the pancreas show co-localizations of the 
InsR with SP (A, B, C, D, E, F) or CGRP (G, H, I, J, K, L) in the Th10 DRG (A, B, C; G, H, I) 
and in the right NG (D, E, F; J, K, L). The scale bar indicates 100 µm and applies to all 
photomicrographs.  
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Figure 6. Pie charts show the relative proportions of the InsR- and SP- or CGRP-IR 
subpopulations of bWGA retrogradely labelled pancreatic DRG and NG neurons. Pie 
charts showing the percentage distributions and overlaps of bWGA-labelled InsR-, SP- and 
CGRP-immunopositive DRG (A, C) and NG (B, D) neurons innervating the pancreas.  
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Table 3. Proportions of bWGA retrogradely labelled InsR-IR pancreatic DRG and NG neurons 
showing CGRP and SP immunoreactivity. 
Target organ (origin) 
CGRP+ neurons (%) SP+ neurons (%) 
pancreas (DRG) 58.35.3 28.41.3 
pancreas (NG) 17.43.6 46.21.9 
Table 4. Proportions of SP-IR retrogradely labelled pancreatic DRG and NG neurons showing 
InsR immunoreactivity. 
Target organ (origin) 
InsR+ neurons (%) 
pancreas (DRG) 42.04.8 
pancreas (NG) 60.24.2 
 
Table 5. Proportions of CGRP-IR retrogradely labelled pancreatic DRG and NG neurons 
showing InsR immunoreactivity. 
Target organ (origin) 
InsR+ neurons (%) 
pancreas (DRG) 52.14.4 
pancreas (NG) 32.02.5 
 
  
39 
 
5. DISCUSSION 
Neurochemical characterization of neuron populations is a critical adjunct for the understanding 
of their function. Knowledge of the molecular traits of nerve cells, in particular PSNs of the 
somato-visceral system, is indispensable in deciphering of and to specifically interfere with 
their function. Exploring molecular similarities and dissimilarities among populations of PSNs 
promotes the understanding of their physiology and pathology, and provides clues for their 
perturbations by e.g., pharmacological means. A prominent example of this approach is the 
utilization of capsaicin’s neuroexcitatory/neurotoxic propensity in the identification of the first 
nociceptive ion channel, termed the capsaicin receptor or the TRPV1 (Caterina et al., 1997). 
Studies conducted in the past two decades have revealed that TRPV1 is the archetypal 
nociceptive ion channel functioning as a molecular integrator of noxious stimuli (Nagy et al., 
2004; Gold and Caterina, 2007; Julius, 2013). Henceforth, any new information as regards the 
neurochemical features of TRPV1-expressing PSNs may point to novel ways to interfere with 
TRPV1 function including the transmission of painful stimuli and local modulation of organ 
functions. 
PSNs belong to the best characterized nerve cell populations of the mammalian nervous system. 
Although a great number of neuron specific proteins, enzymes, peptides, amino acids and lectin 
binding sites were demonstrated in these neurons, it is generally accepted that nociceptive PSNs 
comprise two major subpopulations: the peptidergic and the non-peptidergic populations. It 
should, however, be noted that this classification is somewhat (over)simplified, since in many 
investigations (e.g., Winter et al., 1988; Lindsay et al., 1989), including also our own studies 
(Sántha et al., 2010; Lázár et al., 2018), a moderate but significant overlap has been noted 
between these two populations. Importantly, some specific proteins, such as the TRPV1 
receptor is expressed in both the peptidergic and the non-peptidergic populations of the 
nociceptive PSNs. 
Neurotrophins such as NGF and GDNF significantly contribute to the development, 
differentiation and functional characteristics of peptidergic and non-peptidergic nociceptive 
PSNs. In the last few decades, several studies have revealed that insulin has also a potent 
neurotrophic effect on cultured DRG neurons and sensory nerves as well (Recio-Pinto et al., 
1986b; Fernyhough et al., 1993; Ozkul et al., 2001; Toth et al., 2006; Lázár et al., 2018). It has 
also been demonstrated that insulin exerts its neural actions through the InsR. Further, 
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electrophysiological studies have suggested a role of the InsR in the sensitization of the TRPV1 
ion channel by the archetypal agonist, capsaicin (Sathianathan et al., 2003). In addition, a direct 
effect of insulin on TRPV1 activation was also suggested (Sathianathan et al., 2003). 
Additionally, other findings have revealed that besides sensitization of the TRPV1, insulin 
increases the expression of the TRPV1 protein, too (Lilja et al., 2007).  
Recently, the expression of the InsR has also been demonstrated in both the peptidergic and the 
non-peptidergic populations of rodent PSNs, many of which express the TRPV1 (Sugimoto et 
al., 2000, 2002; Baiou et al., 2007; Lázár et al., 2018). It has been further revealed that the InsR 
is expressed in DRG neurons of unidentified target innervation territories (Baiou et al., 2007; 
Lázár et al., 2018). Although the presence of the InsR was demonstrated in spinal PSNs, 
possible differences in the expression of the InsR in neurons innervating somatic or visceral 
organs was not investigated. Therefore, the primary aim of the experiments summarized in this 
Thesis was to examine the expression of the InsR in target identified somatic and visceral PSNs 
with respect to their possible functional implications. 
First, retrogradely labelled somatic and visceral PSNs identified by retrograde axonal labelling 
were characterized utilizing lectin- and immunohistochemical as well as quantitative 
morphological techniques. Second, labelled pancreatic spinal and vagal PSNs were 
characterized, since PSNs have been shown to be significantly involved in the modulation or 
even initiation of inflammatory processes in both the exocrine and the endocrine pancreas. 
Our findings confirm previous findings which demonstrated that a significant proportion of rat 
PSNs express the InsR (Sathianathan et al., 2003; Baiou et al., 2007; Lázár et al., 2018). 
Importantly, the present experiments revealed a preponderance of InsR expression in visceral 
PSNs as compared to somatic PSNs, suggesting that PSNs innervating visceral organs may be 
more sensitive to the neuromodulatory effects of insulin. Hence, our findings revealed that one-
half of urinary bladder and pancreatic sensory afferent neurons, whereas only one-quarter of 
cutaneous and muscle PSNs expressed the InsR.  
Recent immunohistochemical studies have also revealed that InsR-expressing mouse DRG 
neurons are peripherin-immunopositive and belong to the small sized population of PSNs 
(Baiou et al., 2007). Baiou and his colleagues have also demonstrated that significant 
proportions of InsR-immunopositive mouse DRG neurons express TRPV1, CGRP or bind IB4 
(Baiou et al., 2007). Our findings corroborate and extend previous in vitro observations and, 
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regarding the cell size and the TRPV1-expression pattern of target identified InsR-expressing 
PSNs, suggest that these neurons are nociceptive in character.  
Further, analysis of the TPRV1-immunopositivity of identified InsR-expressing PSNs revealed 
that about two-third of the bWGA-labelled InsR-immunopositive DRG and NG neurons 
innervating the dorsal hind paw skin, the gastrocnemius muscle, the urinary bladder and the 
pancreas express the TRPV1. Hence, in this respect a significant difference between somatic 
and visceral PSNs was not detected. Nonetheless, these findings suggest that a functional 
interaction between the TRPV1 and the InsR may bear of important functional significance 
predominantly in nociceptive PSNs innervating visceral tissues. Earlier studies have also 
suggested that interactions among insulin, the InsR and the TRPV1 expressed in PSNs may 
contribute to pathophysiological processes including, for example, inflammatory changes of the 
skin (Gamse et al., 1987; Santicioli et al., 1987), the dura mater (Dux et al., 2007) and the 
exocrine and endocrine pancreas (Nathan et al., 2001; Razavi et al., 2006; Gram et al., 2007; 
Tsui et al., 2007). The expression of the InsR and the co-expression of the InsR with the TRPV1 
may also bear of important pathophysiological significance under conditions of unbalanced 
plasma insulin level.  
In PSNs retrogradely labelled from the skin and muscle only about one-fifth of the neurons 
displayed InsR-immunoreactivity. The possible functional significance of InsRs and insulin in 
these organs is at present unclear. In earlier studies a marked reduction in cutaneous neurogenic 
plasma extravasation has been demonstrated in streptozotocin diabetic rats. Moreover, 
decreased axon reflex flare reaction was observed in diabetic patients with small fibre 
neuropathy (Kramer et al., 2004). Examination of the axon reflex flare response is a reliable 
measure of cutaneous nociceptor function in both man (Jancsó and Janka, 1981) and 
experimental animals (Barthó et al., 1992). Although the role of the InsR has not been 
considered in this process, subsequent studies showed that local application of insulin was able 
to ameliorate the functional deficits of cutaneous sensory nerves in diabetic patients (Kramer et 
al., 2004). Similarly, administration of insulin has been shown to restore impaired meningeal 
sensory neurogenic vasodilatatory responses in diabetic rats (Dux et al., 2007). Hence, insulin 
and InsRs, which is expressed in sensory nerves may contribute to mechanisms involved in the 
maintenance of the functional integrity of cutaneous nerves and, consequently, the skin.   
Capsaicin-sensitive afferents in the skeletal muscle are essentially involved in local vascular 
and vasomotor reflex responses associated with exercise or chemical stimulation of C-fibres 
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(Kaufman et al., 1982; Mense, 2008). Although many muscle C-fibre afferents are sensitive to 
capsaicin, knowledge on the chemical phenotype of muscle PSNs is modest. Considering the 
available experimental data, it may be assumed that insulin may modulate muscle 
vasodilatatory and nociceptive responses through muscle PSNs which express the TRPV1 and 
the InsR, as shown in the present study.    
One of the most important finding of the present experiments was the observation that visceral 
PSNs innervating the urinary bladder and the pancreas exhibit a preponderance for the 
expression of the InsR as compared with somatic PSNs. It has been revealed that the damage 
of visceral sensory nerves innervating the urinary bladder wall may be involved in the 
development of cystopathies (Dinis et al., 2004b; Charrua et al., 2007), especially which are 
associated with diabetes mellitus and are characterized by increased post voiding residual 
volumes, enhanced bladder capacity and decreased bladder sensation. (Kebapci et al., 2007). 
This assumption is supported by observations of increased bladder capacity and disturbances in 
urinary bladder reflexes and micturition after neonatal capsaicin treatment which produces a 
selective loss of nociceptive C-fibre PSNs (Jancsó et al., 1977; Jancsó and Maggi, 1987). Recent 
findings have revealed that SP and CGRP receptor antagonists, by preventing the release of 
neuropeptides from capsaicin-sensitive afferent nerves, may specifically ameliorate 
inflammatory changes, such as leukocyte rolling and adhesion in the urinary bladder (Jaromi et 
al., 2018). Our findings by showing that about one-half of TRPV1-IR DRG neurons innervating 
the urinary bladder express the InsR, suggest a possible modulatory influence of insulin on 
urinary bladder sensory nerves and, consequently, on bladder functioning under pathological 
conditions. Further, regarding the role of nociceptive sensory nerves in the development of 
bladder pathologies, it can be hypothesized that the interaction among insulin, the InsR and the 
TRPV1 may contribute to the development of cystopathies associated with diabetes mellitus.   
Previously, several studies suggested that TRPV1-expressing sensory neurons contribute to the 
development of  inflammatory processes of both the exocrine and the endocrine pancreas 
(Nathan et al., 2001, 2002; Razavi et al., 2006; Wick et al., 2006; Iwasaki et al., 2013; Schwartz 
et al., 2013). Morphological studies have revealed that a significant proportion of sensory 
nerves innervating the pancreas are capsaicin-sensitive (Sharkey and Williams, 1983; Sharkey 
et al., 1984). Our findings confirm these observations by showing that up to 60% of identified 
small to medium sized pancreatic PSNs in both the thoracolumbar DRGs and the NGs displayed 
TRPV1 immunoreactivity.  
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Early studies on the possible role of nociceptive sensory neurons in inflammatory processes of 
the exocrine pancreas have focused on the effects of capsaicin treatment. It has been revealed 
that neonatal capsaicin treatment significantly diminished the tissue levels of biochemical 
markers and histological changes associated with experimental acute pancreatitis induced by 
caerulein and common pancreaticobiliary duct ligation (Nathan et al., 2002). Further, it has 
been demonstrated that L-arginine-induced necrotizing pancreatitis increased the number of 
spinal neurons expressing c-fos, a marker of neuronal activation, in Rexed's laminae I and II of 
the spinal dorsal horn, a major site of the central termination of nociceptive PSNs which express 
the TRPV1 (Wick et al., 2006). Other studies have showed that mRNA expression of TRPV1 
is increased in rat thoracic DRG neurons after trinitrobenzene sulfonic acid induced chronic 
pancreatitis (Xu et al., 2007). Schwartz and his colleagues have also demonstrated that 
continuous treatment of experimental acute pancreatitis with a TRPV1 antagonist reduced 
pancreatic inflammation and histological alterations. Accordingly, these observations 
suggested that early administration of TRPV1 antagonists may decrease the possibility of the 
development of chronic pancreatitis (Schwartz et al., 2013).  
Similarly, the role of nociceptive PSNs in the development of inflammation in the endocrine 
pancreas has also been raised. Razavi and his colleagues have demonstrated that TRPV1-
positive sensory nerve fibres are important elements of the initiation and progression of type 1 
diabetes mellitus through interfering with local immune and inflammatory processes. They 
have revealed that in NOD mice pre-treatment with capsaicin delayed the onset of diabetes, and 
reduced its incidence compared to control NOD mice (Razavi et al., 2006).  
In addition, the contribution of TRPV1-positive C-fibres in pancreatic tumour development has 
also been shown. mRNA level of TRPV1 is significantly increased in human ductal pancreatic 
adenocarcinoma compared with control. In vitro, RTX alone or in combination with 
chemotherapeutic agents decelerate tumour cell proliferation in pancreatic cancer cell lines 
(Hartel et al., 2006). Ablation of C-fibres by capsaicin treatment slows the progression of ductal 
pancreatic adenocarcinoma in transgenic mice (Saloman et al., 2016). 
The activation of TRPV1 results in the release of pro-inflammatory neuropeptides, such as SP 
and CGRP. In recent years, several studies have demonstrated that rat pancreatic acini and islets 
of Langerhans are innervated by TRPV1-immunopositive sensory fibres which contain CGRP 
and SP suggesting a possible role of sensory neuropeptides in the inflammatory processes of 
both the exocrine and the endocrine pancreas. It has been revealed that injection of capsaicin 
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into the pancreaticobiliary duct induces endocytosis of the NK1R in laminae I-III of the thoracic 
dorsal horn of the rat spinal cord. Moreover, in control NOD mice lower TRPV1 protein 
expression was observed. Further, depressed level of TRPV1-mediated responses such as the 
release of SP was also demonstrated (Razavi et al., 2006). In particular, it has been suggested 
that sensory neuropeptides such as SP and CGRP prevent diabetic changes in pancreas 
(Khachatryan et al., 1997; Razavi et al., 2006). 
Our findings strongly support the observations suggesting a crucial role of TRPV1-positive 
PSNs in the development of pathologies of the pancreas, including acute and chronic 
pancreatitis, diabetes mellitus and tumour development. 
Our quantitative data by demonstrating that one-half and one-quarter of identified pancreatic 
DRG and NG neurons contain CGRP, whereas, more than one-quarter and one-half show SP 
immunoreactivity, provide morphological basis to these findings. Nonetheless, the most 
important finding of the present experiments is the demonstration of InsRs in pancreatic spinal 
and vagal sensory ganglion neurons and its co-localization with the TRPV1, SP and CGRP. In 
the present study, we detected for the first time the presence of InsR in identified pancreatic 
afferent neurons. InsR-immunoreactivity was demonstrated in similar proportions of the 
retrogradely labelled DRG and NG neurons. Our data also demonstrated the co-localization of 
the TRPV1 and the InsR in identified pancreatic PSNs. Indeed, our findings also show that 
relatively high proportions of InsR-IR DRG and NG neurons display SP and CGRP 
immunoreactivities. Conversely, one-half of the CGRP-immunopositive and up to one-quarter 
of the SP-IR DRG and NG neurons display InsR-immunoreactivity.  
Previously, interactions among insulin, the InsRs and nociceptive TPRV1-IR sensory fibres in 
the initiation of pancreatitis and the development of diabetes mellitus have been suggested.  
This is supported by the findings showing that, in the rat, the pancreatic parenchyma, including 
the islets of Langerhans and pancreatic acini, is exposed to very high levels of insulin during 
the secretory process of the hormone (Bendayan, 1993). Insulin, by reaching sensory nerves, 
which have been demonstrated in the immediate surroundings of the islet apparatus (Razavi et 
al., 2006; Gram et al., 2007; Tsui et al., 2007; Iwasaki et al., 2013), and also in the exocrine 
pancreas (Wick et al., 2006; Liddle, 2007; Schneider et al., 2009; Schwartz et al., 2013), may 
trigger the release of inflammatory neuropeptides either directly by activation of neural TRPV1, 
or indirectly, through the modulation of TRPV1 channel opening. Considering the modulating 
role of InsRs on capsaicin-induced activation of TRPV1, it is assumed that activation of neural 
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TRPV1 by insulin through the release of proinflammatory neuropeptides such as CGRP and SP 
may contribute to the formation of a vicious cycle resulting in an exaggeration of pancreatic 
inflammatory processes.  
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6. CONCLUSIONS 
The studies presented of this Thesis was revealed the morphometric and neurochemical 
characteristics of InsR-expressing PSNs innervating somatic and visceral organs. In particular, 
the phenotypic characterization of pancreatic nociceptive DRG and NG neurons was assessed 
in detail.  
Previously, several studies have suggested that insulin can modulate the activation of 
nociceptive PSNs. The importance of the interaction among insulin, InsR and TRPV1 in this 
process has also been indicated. However, data were lacking on the expression of InsR and its 
co-localization with TRPV1 in PSNs innervating different organs. In the experiments 
summarized in this Thesis, we demonstrated, for the first time, the presence of InsRs in 
retrogradely labelled cutaneous, muscle, urinary bladder and pancreatic primary sensory 
neurons. We demonstrated that a high proportion of small to medium sized InsR-expressing 
PSNs display TRPV1-immunoreactivity for these InsR-positive DRG and NG neurons are 
nociceptive in character. Moreover, our quantitative immunohistochemical data revealed a 
preponderance of InsR-immunoreactivity among PSNs which innervate visceral organs. These 
findings suggest that visceral PSNs are more likely to be exposed to the modulatory effects of 
insulin on sensory functions, including neurotrophic, nociceptive and inflammatory processes. 
Considering the newly found co-localization of the InsR with the TRPV1 in identified visceral 
DRG and NG neurons and the functional interplay between these receptors, a significant role 
of InsR-expressing visceral PSNs in the development of visceral inflammatory processes could 
be hypothesized.  
In the recent years, several studies have suggested that peptidergic TRPV1-expressing sensory 
nerves have a role in the development of pancreatic pathologies. Further, it has also been 
demonstrated that an interaction between insulin and the pancreatic nociceptive afferent nerves 
may be contributing to pathological processes affecting both the exocrine and the endocrine 
pancreas. Our quantitative data provide morphological basis for possible functional interactions 
among the nociceptive ion channel TRPV1, the InsR, and the proinflammatory neuropeptides 
SP and CGRP expressed by pancreatic DRG and NG neurons. Based on these observations, a 
new, proinflammatory role of insulin in the pathomechanism of pancreatic pathologies may 
emerge. 
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7. SUMMARY 
Over the past few decades, several studies have demonstrated that insulin, apart from being a 
pivotal regulator of carbohydrate metabolism, is significantly involved in various neuronal 
processes such as neural survival, initiation of neurite outgrowth and regulation of neuronal 
activity. It has also been revealed that neural effects of insulin are mediated by the InsR, which 
has been demonstrated in the nerve tissue, too. In addition, experiments on cultured rat PSNs 
demonstrated that insulin may sensitize the nociceptive ion channel, the TRPV1 by increasing 
the activation of this channel by capsaicin. TRPV1-expressing PSNs comprise over 90% of C-
fibre ganglion cells and are involved in pain sensation and implicated in neurogenic 
inflammatory responses through the release of sensory neuropeptides such as CGRP and SP. 
Further, it has been suggested that interaction among insulin, the InsR and the TRPV1 expressed 
in PSNs may contribute to physiological and pathophysiological processes in various organs. 
Immunohistochemical studies provided further support to this notion by showing a substantial 
co-localization of the TRPV1 and the InsR in rat and mouse PSNs of unidentified target 
innervation territories. The expression of the InsR in nociceptive sensory nerves of different 
organs and tissues may bear of particular interest as regards the modulatory influence of insulin 
on a variety of tissue processes. Hence, exploring the localization of the InsR in PSNs serving 
different organs is of critical importance for the further understanding of the role of these 
particular afferent nerves in physiological and pathological processes.  
Therefore, the aim of the present experiments summarized in this Thesis was to reveal, by using 
hodological and immunohistochemical methods, the expression of the InsR in rat cutaneous, 
muscle, pancreatic and urinary bladder spinal and vagal afferent neurons and its co-localization 
with the TRPV1. Further, considering the importance of nociceptive PSNs in the pathologies 
of both the exocrine and endocrine pancreas, we evaluated morphometric and neurochemical 
properties of identified rat spinal and vagal pancreatic afferent neurons with particular emphasis 
on the co-localization of the InsR with SP and CGRP. 
Our results indicate that almost one-half of the visceral and less than one-quarter of somatic 
PSNs express the InsR. A great majority of these neurons exhibits TRPV1 immunoreactivity. 
Our quantitative data also show that ~15% of somatic and ~30% of visceral spinal PSNs 
displayed InsR and TRPV1 co-localization. Additionally, co-localization of the InsR with SP 
or CGRP was demonstrated in pancreatic spinal and vagal neurons.  
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These findings provide evidence for the co-localization of the InsR and the TRPV1 in somatic 
and visceral PSNs and demonstrate that a higher proportion of visceral PSNs express the InsR 
and display InsR-TRPV1 co-localization. Furthermore, our findings also show that a relatively 
high proportion of pancreatic spinal and vagal PSNs display co-localization of the TRPV1, the 
InsR and sensory neuropeptides. The findings suggest that insulin may modulate TRPV1 
activation and subsequent peptide release from visceral afferents and contribute to nociceptive 
and inflammatory mechanisms of the viscera. 
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